Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
James E. Flynn | Director | 2025-02-27 | 353,249 | $0.93 | $328.87kBuy |
James E. Flynn | Director | 2025-02-27 | 353,249 | $0.93 | $328.87kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Orbimed Israel Biofund GP Limited Partnership | 51.91% | 13,773,653 | $7.58M | Insider |
Erez Chimovits | 17.44% | 4,626,978 | $2.54M | Insider |
Chidozie Ugwumba | 11.30% | 2,997,025 | $1.65M | Insider |
James E. Flynn | 9.40% | 2,494,108 | $1.37M | Insider |
Deerfield Management Company LP | 9.40% | 2,494,108 | $1.37M | Institution |
Nantahala Capital Management LLC | 9.40% | 2,493,309 | $1.37M | Institution |
Takeda Pharmaceutical Co Ltd | 9.31% | 2,470,935 | $1.36M | Insider |
Jonas Grossman | 7.84% | 2,080,217 | $1.14M | Insider |
Morgan Stanley | 6.99% | 1,854,032 | $1.02M | Institution |
Fibrosis Foundation Cystic | 6.74% | 1,787,758 | $983.27k | Insider |